Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions.

导出 OA

翻译打印收藏纠错

作者： Giada,Crescioli ^[1] ; Valentina,Brilli ^[2] ; Cecilia,Lanzi ^[1] ; Andrea,Burgalassi ^[3] ; Alessandra,Ieri ^[3] ; Roberto,Bonaiuti ^[1] ; Elias,Romano ^[3] ; Rinaldo,Innocenti ^[3] ; Guido,Mannaioni ^[1] ; Alfredo,Vannacci ^[4] ; Niccolò,Lombardi ^[5]

作者单位： Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy. ^[1] Tuscan Regional Centre of Pharmacovigilance, Florence, Italy. ^[2] Toxicology Unit, Emergency Department, Careggi University Hospital, Florence, Italy. ^[3] Joint Laboratory of Technological Solutions for Clinical Pharmacology, Pharmacovigilance and Bioinformatics, University of Florence, Florence, Italy. ^[4] Internal Medicine Unit 2, Emergency Department, Careggi University Hospital, Florence, Italy. ^[5] Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. ^[6] Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy. niccolo.lombardi@unifi.it. ^[7] Tuscan Regional Centre of Pharmacovigilance, Florence, Italy. niccolo.lombardi@unifi.it. ^[8] Toxicology Unit, Emergency Department, Careggi University Hospital, Florence, Italy. niccolo.lombardi@unifi.it. ^[9]

关键词 Adverse drug reactions COVID-19 Drug–drug interactions Internal medicine Pharmacovigilance